ID: MRFR/HC/5850-CR | August 2019 | Region: Global | 105 pages
|Market Size||USD 523.20 Million|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Type, Application, and End user|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Nikon Corporation (Japan), Leica Biosystems Nussloch GmbH(Germany), Olympus Corporation(Japan), ZEISS International(Germany), Sakura Finetek USA(US), Inc., Celestron, LLC.( US), Labomed(US), Inc., Hitachi High-Technologies Corporation(Japan), Bruker Corporation(US), and Euromex Microscopen BV (Netherlands)|
|Key Market Opportunities||
|Key Market Drivers||
Frequently Asked Questions (FAQ) :
Pathological microscopes market projected to grow at approximately 4.50% CAGR during the assessment period (2020-2027).
The valuation of the global pathological microscopes market is estimated to increase to USD 523.20 MN by the end of 2023.
Growth in the drug discovery and development sector and streamlined workflow are major tailwinds pushing the growth of the global pathological microscopes market.
North America holds the largest share in the global pathological microscopes market, followed by Europe and the Asia Pacific, respectively.
Sakura Finetek USA, Inc. (U.S.), Hitachi High-Technologies Corporation (Japan), Leica Biosystems Nussloch GmbH (Germany), Euromex Microscopen BV (The Netherlands), ZEISS International (Germany), Celestron LLC (U.S.), Labomed, Inc. (U.S.), Olympus Corporation (Japan), Bruker Corporation (U.S.), and Nikon Corporation (Japan), are some of the top players operating in the global pathological microscopes market.
Global Pathological Microscopes Market - Summary
Pathology concerns itself with the study of diseases via cell, tissue, and blood samples. The evolution of virus and disease strains calls for the need of advanced technological solutions. Pathological microscopes are used to identify or discern the presence of chronic or infectious diseases in the body by pathologists. The global pathological microscopes market is set to touch a valuation of USD 523.20 million by 2023. It can accrue significant revenue at 4.50% CAGR over the forecast period (2018-2023).
The emphasis on drug discovery and development by pharmaceutical companies is likely to trigger the demand for advanced microscopic devices. Pathological microscopes which discern the strength of drugs and vaccines against virulent strains will be in high demand till 2023. Rising prevalence of chronic diseases is predicted to drive the pathological microscopes market. This is evident by the high volume of patients visiting diagnostic centers. According to the Center for Disease Control & Prevention (CDC) in 2016, close to 16.8 million visited physicians.
Automation of laboratory processes to accelerate the diagnosis rate is likely to open up new opportunities for the market. The setup of various public and private diagnostic units to alleviate the burden of patient volume can bolster the pathological microscopes market till 2023.
Upcoming sectors of telemedicine and telepathology which reduces the diagnosis period of assays can pave open new growth avenues for the market. These sectors can use a mix of advanced processes and provide outcomes in real-time.
Types of microscopes include optical microscope, compound microscope, digital microscope, fluorescence microscope, electron microscope, and others. Electron microscopes had accounted for a major market share in 2017 thanks to its capacity to magnify the resolution of samples by 300 million. Its increased application in life sciences is likely to boost its segment exponentially by 2023. But digital microscopes are expected to take the lead as the most vouched instrument owing to the image sample being viewed clearly without any external devices. Development of new microscopy techniques, advances in digital cameras, and novel printing techniques are factors which can drive its phenomenal growth in the pathological microscopes market.
Major applications of these devices include tissue scanning, bodily fluids, and others. Bodily fluids accounted for the lion’s share in the pathological microscopes market owing to blood samples being a highly trusted source for discerning the presence of comorbidities. They are being used to detect blood-related disorders such as leukemia at an early stage. On the other hand, tissue scanning is the second-most effective method by detecting small ruptures in appendix and fallopian tubes. High incidence of cancer is ensured to drive its demand in the pathological microscopes market.
End-users include pathology & diagnostic laboratories, forensic laboratories, hospitals & clinics, and others. Pathology & diagnostic laboratories can contribute to the market thanks to possessing an arsenal of advanced equipment and skilled personnel. Hospitals and clinics are touted to be the biggest end-user of the pathological microscopes market owing to their ability to handle high patient volume.
Geographic segmentation of the pathological microscopes market reveals details regarding Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).
The Americas are likely to reign supreme in the pathological microscopes market owing to increasing funding in research and development activities. High prevalence of chronic diseases and discovery of novel drugs to treat rapidly evolving comorbidities is likely to propel the demand for microscopes in the region.
The APAC pathological microscopes market is projected to grow at a rapid pace thanks to a surplus of clinical researchers, boom in life sciences, and inflow of capital by firms to expedite drug discovery and development. On the other hand, Europe can experience a modest growth rate owing to increasing research and development (R&D) activities and support by government bodies in terms of funding.
Major players in the pathological microscopes market include Labomed, Inc. (U.S.), Nikon Corporation (Japan), Celestron LLC (U.S.), Olympus Corporation (Japan), Sakura Finetek USA, Inc. (U.S.), Bruker Corporation (U.S.), Hitachi High-Technologies Corporation (Japan), ZEISS International (Germany), Euromex Microscopen BV (The Netherlands), and Leica Biosystems Nussloch GmbH (Germany).
This table of content is tentative and subject to change as the research progresses.
Please Note: Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.
1.1 Company Market Share Analysis
Numerous players are operating in the global pathology microscopes market. Some of the big players have captured a significant share in the global market, taking advantage of their strong position and presence in the number of countries and regions across the world. In the global pathology microscopes market, major companies are opting for new product launches, strategic partnerships, and collaboration to strengthen their market position.
FIGURE 1 GLOBAL PATHOLOGY MICROSCOPES MARKET, MARKET SHARE ANALYSIS 2017 (% SHARE)
Source: MRFR Analysis
The top players in the global pathology microscopes market are Olympus Corporation, Nikon Corporation, and Leica Biosystems Nussloch GmbH.
Olympus Corporation accounted for 55% of the global pathology microscopes market share in 2017. It is a market leader in global pathology microscopes market. The company operates in business segments including medical business, scientific solutions business, imaging business, and others. The company emphasizes on providing top quality products with advance technology. Olympus Corporation is expanding its portfolio by acquiring other market players. for instance, In May 2017 , the company has acquired Image Stream Medical, Inc. for USD 87 million.
Leica Biosystems Nussloch GmbH accounted for the second-largest market share of 20.3% in 2017. It operates as a subsidiary of Danaher Corporation. The company has strong presence in global pathology microscopes market. The company has six major plants all over the world and present in more than 100 countries. Leica biosystems has strong distribution network in all the major markets. strategic partnerships, collaborations and new product launches are playing important role in development of the company. For instance, in October 2017, the company has signed distribution partnership with Polytech Domilens to strengthen its position in microscopes market of Germany.
Nikon Corporation operates in following segments imaging products business, precision equipment business, healthcare business, industrial metrology and others. The company accounted for 13.9% of the total market share in 2017. The company is launching new products to capture the untapped markets. Nikon corporation is present in more than 70 countries and 300 locations all over the world and has strong brand name in instruments market.
Some other major players operating in the Global Pathological Microscopes Market are Sakura Finetek USA, Inc., Celestron, LLC., Labomed, Inc., Hitachi High-Technologies Corporation, Bruker Corporation, Euromex Microscopen bv and others.